Literature DB >> 25074393

Proposed ratios and cutoffs for the assessment of lipodystrophy in HIV-seropositive individuals.

R A Beraldo1, H S Vassimon2, D C Aragon3, A M Navarro1, F J Albuquerque de Paula1, M C Foss-Freitas1.   

Abstract

OBJECTIVES: To propose objective ratios using anthropometry and dual-energy X-ray absorptiometry (DXA) and to suggest cutoff points for them in order to classify lipodystrophy in male patients.
METHODS: It is a cross-sectional study. DXA was applied and anthropometric measurements were performed in 100 men on highly active antiretroviral therapy. Receiver operating characteristic curves were used to propose cutoffs. Individuals were divided in without (lipo-) or with (lipo+) lipodystrophy and their metabolic parameters were compared.
RESULTS: The following ratios were proposed: fat mass ratio by DXA (FMR), waist thigh ratio (WTR), waist calf ratio (WCR), and arm to trunk ratio (ATR). The best cutoffs observed for FMR, WTR and ATR were 1.26, 1.74 and 2.08, respectively. Using the proposed cutoff for FMR, we observed worse metabolic profile, with increased tryglicerides, fasting serum glucose and more hypercholesterolemia in the lipo+ group. WTR and ATR showed a significant correlation with FMR.
CONCLUSIONS: Anthropometric ratios (WTR/ATR) and FMR can be used to aid the diagnosis of lipodystrophy in order to contribute to a more accurate and earlier diagnosis permitting intervention and even preventing metabolic disturbances.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25074393     DOI: 10.1038/ejcn.2014.149

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  20 in total

1.  Subcutaneous lipectomy causes a metabolic syndrome in hamsters.

Authors:  R V Weber; M C Buckley; S K Fried; J G Kral
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2000-09       Impact factor: 3.619

2.  Dramatic improvement in survival among adult Brazilian AIDS patients.

Authors:  Jose Ricardo P Marins; Leda F Jamal; Sanny Y Chen; Marilisa B Barros; Esther S Hudes; Aristides A Barbosa; Pedro Chequer; Paulo R Teixeira; Norman Hearst
Journal:  AIDS       Date:  2003-07-25       Impact factor: 4.177

Review 3.  Current perspectives on HIV-associated lipodystrophy syndrome.

Authors:  Ana Milinkovic; Esteban Martinez
Journal:  J Antimicrob Chemother       Date:  2005-05-19       Impact factor: 5.790

4.  Increased resting energy expenditure, fat oxidation, and food intake in patients with highly active antiretroviral therapy-associated lipodystrophy.

Authors:  Jussi Sutinen; Hannele Yki-Järvinen
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-10-24       Impact factor: 4.310

5.  HIV-associated lipodystrophy syndrome: A review of clinical aspects.

Authors:  Jean-Guy Baril; Patrice Junod; Roger Leblanc; Harold Dion; Rachel Therrien; Franãois Laplante; Julian Falutz; Pierre Côté; Marie-Nicole Hébert; Richard Lalonde; Normand Lapointe; Dominic Lévesque; Lyse Pinault; Danielle Rouleau; Cécile Tremblay; Benoãt Trottier; Sylvie Trottier; Chris Tsoukas; Karl Weiss
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-07       Impact factor: 2.471

6.  Fat mass ratio: an objective tool to define lipodystrophy in hiv-infected patients under antiretroviral therapy.

Authors:  Paula Freitas; Ana Cristina Santos; Davide Carvalho; Jorge Pereira; Rui Marques; Esteban Martinez; António Sarmento; José Luís Medina
Journal:  J Clin Densitom       Date:  2010-03-27       Impact factor: 2.617

7.  An objective case definition of lipodystrophy in HIV-infected adults: a case-control study.

Authors:  A Carr; S Emery; M Law; R Puls; J D Lundgren; W G Powderly
Journal:  Lancet       Date:  2003-03-01       Impact factor: 79.321

8.  Longitudinal anthropometric changes in HIV-infected and HIV-uninfected men.

Authors:  Todd Brown; Zhaojie Wang; Haitao Chu; Haito Chu; Frank J Palella; Lawrence Kingsley; Mallory D Witt; Adrian S Dobs
Journal:  J Acquir Immune Defic Syndr       Date:  2006-11-01       Impact factor: 3.731

9.  Increased intramyocellular lipid accumulation in HIV-infected women with fat redistribution.

Authors:  Martin Torriani; Bijoy J Thomas; Robert B Barlow; Jamie Librizzi; Sara Dolan; Steven Grinspoon
Journal:  J Appl Physiol (1985)       Date:  2005-10-13

10.  A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.

Authors:  A Carr; K Samaras; S Burton; M Law; J Freund; D J Chisholm; D A Cooper
Journal:  AIDS       Date:  1998-05-07       Impact factor: 4.177

View more
  8 in total

1.  Spectrum of disease associated with partial lipodystrophy: lessons from a trial cohort.

Authors:  Nevin Ajluni; Rasimcan Meral; Adam H Neidert; Graham F Brady; Eric Buras; Barbara McKenna; Frank DiPaola; Thomas L Chenevert; Jeffrey F Horowitz; Colleen Buggs-Saxton; Amit R Rupani; Peedikayil E Thomas; Marwan K Tayeh; Jeffrey W Innis; M Bishr Omary; Hari Conjeevaram; Elif A Oral
Journal:  Clin Endocrinol (Oxf)       Date:  2017-03-27       Impact factor: 3.478

2.  Effect of 1-year oral cholecalciferol on a metabolic profile and blood pressure in poor-controlled type 2 diabetes mellitus: an open-label randomized controlled pilot study.

Authors:  M Barale; R Rossetto Giaccherino; E Ghigo; M Procopio
Journal:  J Endocrinol Invest       Date:  2020-08-17       Impact factor: 4.256

3.  Comparing the Ability of Anthropometric Indicators in Identifying Metabolic Syndrome in HIV Patients.

Authors:  Rebeca Antunes Beraldo; Gabriela Cristina Meliscki; Bruna Ramos Silva; Anderson Marliere Navarro; Valdes Roberto Bollela; André Schmidt; Maria Cristina Foss-Freitas
Journal:  PLoS One       Date:  2016-02-26       Impact factor: 3.240

4.  H3Africa AWI-Gen Collaborative Centre: a resource to study the interplay between genomic and environmental risk factors for cardiometabolic diseases in four sub-Saharan African countries.

Authors:  M Ramsay; N Crowther; E Tambo; G Agongo; V Baloyi; S Dikotope; X Gómez-Olivé; N Jaff; H Sorgho; R Wagner; C Khayeka-Wandabwa; A Choudhury; S Hazelhurst; K Kahn; Z Lombard; F Mukomana; C Soo; H Soodyall; A Wade; S Afolabi; I Agorinya; L Amenga-Etego; S A Ali; J D Bognini; R P Boua; C Debpuur; S Diallo; E Fato; A Kazienga; S Z Konkobo; P M Kouraogo; F Mashinya; L Micklesfield; S Nakanabo-Diallo; B Njamwea; E Nonterah; S Ouedraogo; V Pillay; A M Somande; P Tindana; R Twine; M Alberts; C Kyobutungi; S A Norris; A R Oduro; H Tinto; S Tollman; O Sankoh
Journal:  Glob Health Epidemiol Genom       Date:  2016-11-22

5.  Lipodystrophy diagnosis in people living with HIV/AIDS: prediction and validation of sex-specific anthropometric models.

Authors:  André P Dos Santos; Anderson M Navarro; Andiara Schwingel; Thiago C Alves; Pedro P Abdalla; Ana Claudia R Venturini; Rodrigo C de Santana; Dalmo R L Machado
Journal:  BMC Public Health       Date:  2018-06-27       Impact factor: 3.295

Review 6.  DXA-Derived Adiposity and Lean Indices for Management of Cardiometabolic and Musculoskeletal Frailty: Data Interpretation Tricks and Reporting Tips.

Authors:  Marco A Minetto; Chiara Busso; Piera Lalli; Giulia Gamerro; Giuseppe Massazza
Journal:  Front Rehabil Sci       Date:  2021-10-20

7.  Endoplasmic reticulum stress activation in adipose tissue induces metabolic syndrome in individuals with familial partial lipodystrophy of the Dunnigan type.

Authors:  Maria C Foss-Freitas; Rafael C Ferraz; Luciana Z Monteiro; Patricia M Gomes; Ricardo Iwakura; Luiz Carlos C de Freitas; Milton C Foss
Journal:  Diabetol Metab Syndr       Date:  2018-02-09       Impact factor: 3.320

8.  A pilot randomized aerobic exercise trial in older HIV-infected men: Insights into strategies for successful aging with HIV.

Authors:  Krisann K Oursler; John D Sorkin; Alice S Ryan; Leslie I Katzel
Journal:  PLoS One       Date:  2018-06-12       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.